EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for BCYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.7224
March 31, 2026 -0.8714
December 31, 2025 -0.2901
September 30, 2025 -0.8474
June 30, 2025 -1.154
March 31, 2025 -0.8814
December 31, 2024 -0.744
September 30, 2024 -0.7439
June 30, 2024 -0.7666
March 31, 2024 -0.6238
December 31, 2023 -1.168
September 30, 2023 -1.254
June 30, 2023 -1.416
March 31, 2023 -1.314
December 31, 2022 -1.016
September 30, 2022 -0.9471
June 30, 2022 -0.897
March 31, 2022 -0.9257
Date Value
December 31, 2021 -0.6105
September 30, 2021 -0.5835
June 30, 2021 -0.7433
March 31, 2021 -0.7351
December 31, 2020 -0.8349
September 30, 2020 -0.5312
June 30, 2020 -0.6718
March 31, 2020 -0.6296
December 31, 2019 -0.2491
September 30, 2019 -0.5264
June 30, 2019 -1.393
March 31, 2019 -0.4944
December 31, 2018 -0.4463
September 30, 2018 -0.4304
June 30, 2018 -0.2779
March 31, 2018 -0.1441
December 31, 2017 -0.3618

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc -0.1472
Akari Therapeutics Plc -2.404
Biodexa Pharmaceuticals Plc --
DBV Technologies SA -0.5804
Cellectis SA -0.2165